drugset
drugset / Trial / NCT05405543

A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants

NCT05405543 ↗

Phase 1 Completed 36 enrolled Bristol-Myers Squibb
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of both single and multiple dose drug levels of MYK-224 in healthy adult Japanese participants.

Timeline

Start
2022-07-12
Primary completion
2022-11-16
Completion
2022-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject DELOCAMTEN Small molecule — —

Indications

No indication recorded.